Optical sensing of biomedically important polyionic drugs using nano-sized gold particles

Biosensors & Bioelectronics
Bikash Kumar Jena, C Retna Raj

Abstract

A simple optical method for the sensing of biomedically important polyionic drugs, protamine and heparin based on the reversible aggregation and de-aggregation of gold nanoparticles (AuNPs) is described. The polycationic protamine induces the aggregation of negatively charged citrate-stabilized AuNPs, resulting in a shift in the surface plasmon (SP) band and a consequent color change of the AuNPs from red to blue. Addition of polyanionic heparin dissipates the aggregated AuNPs due to its strong affinity to protamine and the blue color changes to the native color. The color change was monitored using UV-vis spectrophotometry. The aggregation and de-aggregation was confirmed by transmission electron microscopic (TEM) measurements. The degree of aggregation and de-aggregation is proportional to the concentration of added protamine and heparin, allowing their quantitative detection. The change in the absorbance and SP band position has been used to monitor the concentration of protamine and heparin. This optical method can quantify protamine and heparin as low as 0.1 microg/ml and 0.6 microg/ml, respectively and the calibration is linear for a wide range of concentration.

References

May 1, 1978·British Medical Bulletin·T W BarrowcliffeD Thomas
Mar 1, 1985·Anesthesia and Analgesia·J C Horrow
May 2, 1966·JAMA : the Journal of the American Medical Association·P G Hattersley
Jul 1, 1982·Clinica Chimica Acta; International Journal of Clinical Chemistry·J van PuttenH C Hemker
Jan 12, 1999·Biosensors & Bioelectronics·K Gaus, E A Hall
Nov 28, 2001·Analytical Chemistry·B NeimanO Lev
Jul 3, 2003·Journal of the American Chemical Society·Kae SatoMizuo Maeda
Mar 12, 2004·Journal of the American Chemical Society·Hideaki ItohYoshiki Chujo
Sep 24, 2004·Journal of the American Chemical Society·Valeri PavlovItamar Willner
Feb 23, 2005·Langmuir : the ACS Journal of Surfaces and Colloids·Christopher J OrendorffCatherine J Murphy
Apr 14, 2005·Chemical Reviews·Nathaniel L Rosi, Chad A Mirkin
Aug 23, 2005·Chemical Communications : Chem Comm·Charng-Sheng TsaiChao-Tsen Chen
Sep 1, 2005·Analytical Chemistry·Jidong GuoShigeru Amemiya
Sep 15, 2005·Proteins·Myer R Salaman, Jim Warwicker
Sep 21, 2005·Langmuir : the ACS Journal of Surfaces and Colloids·Scott H BrewerStefan Franzen
Oct 14, 2005·Journal of the American Chemical Society·Alexey Shvarev, Eric Bakker
Nov 1, 2005·Nucleic Acids Research·Jishan LiRu-Qin Yu
Nov 3, 2005·Langmuir : the ACS Journal of Surfaces and Colloids·Anand Gole, Catherine J Murphy
Jun 28, 2006·The Journal of Physical Chemistry. B·Sung Yong ParkGeorge C Schatz
Sep 29, 2006·The Journal of Physical Chemistry. B·Kyeong-Seok Lee, Mostafa A El-Sayed

❮ Previous
Next ❯

Citations

Apr 15, 2011·Langmuir : the ACS Journal of Surfaces and Colloids·Xianfeng ZhangXuezhong Du
Aug 21, 2013·International Journal of Analytical Chemistry·Yixi XieEnju Wang
May 18, 2010·Biomaterials·Yao-Chen ChuangChih-Sheng Lin
Nov 7, 2015·Luminescence : the Journal of Biological and Chemical Luminescence·B RezaeiAli A Ensafi
Jan 10, 2017·ACS Applied Materials & Interfaces·Long ZhaoXiaohong Li
Jan 1, 2009·Sensors·Xueqing ZhangDaxiang Cui
May 8, 2010·Organic & Biomolecular Chemistry·Peter-Korbinian Müller-GraffRoland Krämer
Sep 11, 2013·Chemical Society Reviews·Stephen M BromfieldDavid K Smith
Dec 14, 2011·Chemistry, an Asian Journal·Ramendra Sundar Dey, C Retna Raj
Jul 30, 2011·Advanced Materials·Yujun SongXiaogang Qu
Mar 20, 2013·Chemical Society Reviews·Aicheng Chen, Sanghamitra Chatterjee
Nov 18, 2010·Journal of the American Chemical Society·Christina A Fields-ZinnaRoyce W Murray
May 13, 2015·Chemical Reviews·Jiasheng WuJong Seung Kim
Oct 31, 2019·Langmuir : the ACS Journal of Surfaces and Colloids·Anup Kumar GhoshPrasanta Kumar Das

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.